Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum prostate-specific antigen elevation in the post-radical prostatectomy patient

S B Malkowicz1

  • 1Department of Surgery, University of Pennsylvania Medical Center, Philadelphia, USA.

The Urologic Clinics of North America
|November 1, 1996
PubMed
Summary

Managing rising prostate-specific antigen levels after prostatectomy is challenging due to difficulties in locating recurrence and unproven survival benefits of treatments. Individualized patient care is essential for effective post-prostatectomy serum prostate-specific antigen management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A method to improve reconstruction of the distribution of hemoglobin, oxygenation, and MLu concentration in the human prostate before and after photodynamic therapy.

Proceedings of SPIE--the International Society for Optical Engineering·2015
Same author

A heterogeneous algorithm for PDT dose optimization for prostate.

Proceedings of SPIE--the International Society for Optical Engineering·2015
Same author

Steady state expression of cell-cycle regulatory genes in prostate carcinoma cell lines.

Urologic oncology·2011
Same author

Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy?

Urology·2008
Same author

Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study.

The Journal of urology·2007
Same author

Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men.

The Journal of urology·2007

Area of Science:

  • Urology
  • Oncology
  • Medical Management

Background:

  • Postprostatectomy serum prostate-specific antigen (PSA) elevation indicates potential cancer recurrence.
  • Accurate localization of recurrent prostate cancer is a significant clinical challenge.
  • Evidence supporting survival benefits for current therapies remains limited.

Purpose of the Study:

  • To review the challenges in managing postprostatectomy PSA elevation.
  • To highlight the difficulties in determining the precise location of recurrence.
  • To emphasize the need for individualized treatment strategies.

Main Methods:

  • Review of current literature on prostate cancer recurrence after prostatectomy.
  • Analysis of diagnostic challenges in localizing PSA recurrence.

Related Experiment Videos

  • Evaluation of existing therapeutic options and their survival data.

    • Main Results:

    • Inability to accurately pinpoint the site of PSA recurrence complicates management decisions.
    • Limited data exists to demonstrate a definitive survival advantage for available treatment options.
    • Current therapeutic approaches lack robust evidence for widespread efficacy.

    Conclusions:

    • Effective management of postprostatectomy PSA elevation requires addressing diagnostic limitations.
    • Individualized treatment plans are crucial due to varied patient factors and limited evidence.
    • Further research is needed to improve recurrence detection and therapeutic outcomes.